Cargando…

Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study

OBJECTIVES: Although B-type natriuretic peptide (BNP) and highly sensitive cardiac troponin T (cTnT) are useful for the evaluation of clinical features in various cardiovascular diseases, there are comparatively few data regarding the utility of these parameters in patients with hypertrophic obstruc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Shunichi, Takano, Hitoshi, Matsuda, Junya, Chinen, Daigo, Kitamura, Mitsunobu, Murai, Koji, Asai, Kuniya, Yasutake, Masahiro, Takayama, Morimasa, Shimizu, Wataru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166252/ https://www.ncbi.nlm.nih.gov/pubmed/25231494 http://dx.doi.org/10.1136/bmjopen-2014-005968

Ejemplares similares

Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using (18)F-fluorodeoxyglucose positron emission tomography
por: Aoyama, Rie, et al.
Publicado: (2017)

Cardiac MR Imaging of Hypertrophic Cardiomyopathy: Techniques, Findings, and Clinical Relevance
por: Amano, Yasuo, et al.
Publicado: (2018)

Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy
por: Ishihara, Kakeru, et al.
Publicado: (2023)

Rapid Fatal Progression and Autopsy Findings of Effusive-Constrictive Pericarditis With Hypertrophic Cardiomyopathy
por: Hiruma, Takashi, et al.
Publicado: (2023)

Atrial fibrillation deteriorates tricuspid regurgitation following implantable cardioverter defibrillator lead placement in patient with hypertrophic obstructive cardiomyopathy
por: Mohri, Takato, et al.
Publicado: (2017)

Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy
por: Imori, Yoichi, et al.
Publicado: (2019)

Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy
por: Zhang, Changlin, et al.
Publicado: (2016)

Cardiac Troponin I and T as Prognostic Markers in Cats with Hypertrophic Cardiomyopathy
por: Langhorn, R., et al.
Publicado: (2014)

Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy
por: Hori, Yasutomo, et al.
Publicado: (2018)

IgG4-related periarteritis in the coronary artery and subclinical pericarditis assessed the presence and monitoring of therapy response by PET and CT scan
por: Matsuda, Junya, et al.
Publicado: (2018)

Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance
por: Suzuki, Keishi, et al.
Publicado: (2016)

An In Silico Analysis of Troponin I Mutations in Hypertrophic Cardiomyopathy of Indian Origin
por: Ramachandran, Gayatri, et al.
Publicado: (2013)

Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy
por: Rajtar-Salwa, Renata, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy Mutations of Troponin Reveal Details of Striated Muscle Regulation
por: Chalovich, J. M., et al.
Publicado: (2022)

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2015)

Extracellular volume fraction is associated with B-type natriuretic peptide in hypertrophic cardiomyopathy
por: Wong, Timothy C, et al.
Publicado: (2014)

Genetic variation in exon 5 of troponin - I gene in hypertrophic cardiomyopathy cases
por: Annapurna, S. D., et al.
Publicado: (2007)

Plasma Cardiac Troponin I Concentration and Cardiac Death in Cats with Hypertrophic Cardiomyopathy
por: Borgeat, K., et al.
Publicado: (2014)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

Elevation of high‐sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2020)

Complete Resolution of Left Ventricular Outflow Tract Obstruction After Spontaneous Mitral Valve Chordal Rupture in a Patient With Hypertrophic Cardiomyopathy
por: Ieki, Hirotaka, et al.
Publicado: (2019)

Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014
por: Rajtar-Salwa, Renata, et al.
Publicado: (2017)

Status of Medical Care and Management Requirements of Elderly Patients With Heart Failure in a Comprehensive Community Health System　― Survey of General Practitioners’ Views ―
por: Tsukada, Yayoi Tetsuou, et al.
Publicado: (2021)

Sex Differences in Time-Dependent Changes in B-Type Natriuretic Peptide in Hypertrophic Cardiomyopathy
por: Enzan, Nobuyuki, et al.
Publicado: (2021)

Upstream Enzyme of Natriuretic Peptide Pathway: Is Soluble Corin a Predictor of Future Stroke Events?
por: Kitamura, Mitsunobu
Publicado: (2022)

Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy
por: Fujita, Etsuko, et al.
Publicado: (2013)

Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy
por: Liu, Limin, et al.
Publicado: (2020)

Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy
por: Fahed, Akl C., et al.
Publicado: (2020)

Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study
por: Kubo, Toru, et al.
Publicado: (2015)

N-terminal pro-brain natriuretic peptide and adverse outcomes in Chinese patients with hypertrophic cardiomyopathy
por: Zhang, Zeng-Lei, et al.
Publicado: (2022)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca(2+)-sensitivity and suppress the modulation of Ca(2+)-sensitivity by troponin I phosphorylation()
por: Messer, Andrew E., et al.
Publicado: (2016)

Sexual dimorphism in cardiac transcriptome associated with a troponin C murine model of hypertrophic cardiomyopathy
por: Dieseldorff Jones, Karissa M., et al.
Publicado: (2020)

Anomalous structural dynamics of minimally frustrated residues in cardiac troponin C triggers hypertrophic cardiomyopathy
por: Marques, Mayra A., et al.
Publicado: (2021)

Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant I79N
por: Shafaattalab, Sanam, et al.
Publicado: (2021)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

Painful and painless myocardial ischemia detected by elevated level of high-sensitive troponin in patients with hypertrophic cardiomyopathy
por: Gębka, Adam, et al.
Publicado: (2018)

Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation
por: Veltri, Tiago, et al.
Publicado: (2017)

Intestinal angina in a patient with hypertrophic obstructive cardiomyopathy: a case report
por: Hamaoka, Takuto, et al.
Publicado: (2016)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a0unolsj73ht2o731fdv1s82rp